Archive for February 2017
Veloxis Pharma to Shut Down New Jersey Office, Moving All Operations to North Carolina
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×450-stocks2.jpg" NAME"Veloxis Pharma to Shut Down New Jersey Office, Moving All Operations to North Carolina" ALT"Veloxis Pharma to Shut Down New Jersey Office, Moving All Operations to North Carolina"March 1, 2017By Alex Keown… Source: BioSpace
Read MoreAcceleron Pharma Reports Fourth Quarter And Year Ended 2016 Operational And Financial Results
Life Sciences Jobs … Source: BioSpace
Read MoreNovartis AG Puts Cancer Hopes on 4 Star Scientists Poached From Harvard Last Year
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×400-novartis.jpg" NAME"Novartis AG Puts Cancer Hopes on 4 Star Scientists Poached From Harvard Last Year" ALT"Novartis AG Puts Cancer Hopes on 4 Star Scientists Poached From Harvard Last Year"March 1, 2017By Alex Keown, BioSpace… Source: BioSpace
Read MoreHygieia Completes Acquisition Of Global Food Safety Diagnostics Business From DuPont
Life Sciences Jobs … Source: BioSpace
Read MoreHalozyme Reports Fourth Quarter And Full Year 2016 Financial Results
Life Sciences Jobs … Source: BioSpace
Read MoreAvoid These 3 Biotech Stocks Like the Plague
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×450-stocks.jpg" NAME"Avoid These 3 Biotech Stocks Like the Plague" ALT"Avoid These 3 Biotech Stocks Like the Plague"March 1, 2017By Alex Keown, BioSpace.com Breaking News StaffCHICAGO Often we tout analyst reports… Source: BioSpace
Read More<b>Phosphorus</b> Announces Formation Of Scientific Advisory Board
Life Sciences Jobs … Source: BioSpace
Read More<b>President Trump</b>: Keep Your <b>Peter</b> (<b>Thiel</b>) Out Of Our FDA Politics
Life Sciences Jobs … Source: BioSpace
Read MoreThermo Fisher Scientific Declares Quarterly Dividend
Life Sciences Jobs … Source: BioSpace
Read MoreChinese API Maker Cited Over Data Integrity in FDA Warning Letter
A Chinese API maker relied on manipulated data and incomplete records to make decisions on batch releases, prompting the FDA to issue a warning letter to the company over data integrity. Source: Drug Industry Daily
Read More